Abstract
Camptothecin (CPT), obtained from Camptotheca acuminata (Nyssaceae), is a quinoline type of alkaloid. Apart from various traditional uses, it is mainly used as a potential cytotoxic agent acting against a variety of cancer cell lines. Though searches have been continued for last six decades, still it is a demanding task to design potent and cytotoxic CPTs. Different CPT analogs are synthesized to enhance the cytotoxic potential as well as to increase the pharmacokinetic properties of these analogs. Some of these analogs were proven to be clinically effective in different cancer cell lines. In this article, different CPT analogs have been highlighted extensively to get a detail insight about the structure-property relationships as well as different quantitative structure-activity relationships (QSARs) modeling of these analogs are also discussed. This study may be beneficial for designing newer CPT analogs in future.
Keywords: Camptothecin, homocamptothecin, topoisomerase, cytotoxicity, cancer cell lines, structure-activity relationship, quantitative structure-activity relationship.
Anti-Cancer Agents in Medicinal Chemistry
Title:A Review on Camptothecin Analogs with Promising Cytotoxic Profile
Volume: 18 Issue: 13
Author(s): Sk. Abdul Amin, Nilanjan Adhikari, Tarun Jha*Shovanlal Gayen*
Affiliation:
- Natural Science Laboratory, Division of Medicinal and Pharmaceutical Chemistry, Department of Pharmaceutical Technology, P. O. Box 17020, Jadavpur University, Kolkata 700032, West Bengal,India
- Laboratory of Drug Design and Discovery, Department of Pharmaceutical Sciences, Dr. Harisingh Gour University, Sagar 470003, Madhya Pradesh,India
Keywords: Camptothecin, homocamptothecin, topoisomerase, cytotoxicity, cancer cell lines, structure-activity relationship, quantitative structure-activity relationship.
Abstract: Camptothecin (CPT), obtained from Camptotheca acuminata (Nyssaceae), is a quinoline type of alkaloid. Apart from various traditional uses, it is mainly used as a potential cytotoxic agent acting against a variety of cancer cell lines. Though searches have been continued for last six decades, still it is a demanding task to design potent and cytotoxic CPTs. Different CPT analogs are synthesized to enhance the cytotoxic potential as well as to increase the pharmacokinetic properties of these analogs. Some of these analogs were proven to be clinically effective in different cancer cell lines. In this article, different CPT analogs have been highlighted extensively to get a detail insight about the structure-property relationships as well as different quantitative structure-activity relationships (QSARs) modeling of these analogs are also discussed. This study may be beneficial for designing newer CPT analogs in future.
Export Options
About this article
Cite this article as:
Amin Abdul Sk. , Adhikari Nilanjan , Jha Tarun *, Gayen Shovanlal *, A Review on Camptothecin Analogs with Promising Cytotoxic Profile, Anti-Cancer Agents in Medicinal Chemistry 2018; 18 (13) . https://dx.doi.org/10.2174/1871520618666180327140956
DOI https://dx.doi.org/10.2174/1871520618666180327140956 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
Call for Papers in Thematic Issues
Induction of cell death in cancer cells by modulating telomerase activity using small molecule drugs
Telomeres are distinctive but short stretches present at the corners of chromosomes and aid in stabilizing chromosomal makeup. Resynthesis of telomeres supported by the activity of reverse transcriptase ribonucleoprotein complex telomerase. There is no any telomerase activity in human somatic cells, but the stem cells and germ cells undergone telomerase ...read more
Role of natural compounds as anti anti-cancer agents
Cancer is considered the leading cause of worldwide mortality, accounting for nearly 10 million deaths in 2022. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy remains an important approach in treatment o f several types of cancers, even though ...read more
Signaling and enzymatic modulators in cancer treatment
Cancer accounts for nearly 10 million deaths in 2022 and is considered the leading cause of worldwide mortality. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy, radiotherapy and surgery are the most important approach for the treatment of several ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Transmembrane Phosphatases and Cancer Development, the Role of Protein Tyrosine Phosphatase-kappa (PTPκ) and Protein Tyrosine Phosphatase-mu (PTPμ)
Current Signal Transduction Therapy Editorial: [Hot Topic: Molecular Pathology in Therapeutics: Where are We Now, and Where are We Going?]
Current Drug Targets In vitro Evaluation of Gadolinium-Silica Mesoporous Nanoparticles- Monoclonal Antibody: Potential Nanoprobe for Prostate Cancer Cell Imaging
Current Molecular Imaging (Discontinued) Folic Acid Conjugated Chitosan Nanoparticles for Tumor Targeting of Therapeutic and Imaging Agents
Pharmaceutical Nanotechnology Importance of ABC Transporters in Drug Development
Current Pharmaceutical Design Autophagy : Moving Benchside Promises to Patient Bedsides
Current Cancer Drug Targets The Impact of In Vitro Fertilization on the Health of the Mother and the Offspring
Current Women`s Health Reviews Targeting the Multifaceted HuR Protein, Benefits and Caveats
Current Drug Targets Targeting ATP7A to Increase the Sensitivity of Neuroblastoma Cells to Retinoid Therapy
Current Cancer Drug Targets An In Silico Immunogenicity Analysis for PbHRH: An Antiangiogenic Peptibody by Fusing HRH Peptide and Human IgG1 Fc Fragment
Current Bioinformatics Melatonin, its Metabolites and its Synthetic Analogs as Multi-Faceted Compounds: Antioxidant, Prooxidant and Inhibitor of Bioactivation Reactions
Current Medicinal Chemistry Beta-Blockers: Effects on Bone Mineral Density and Fracture Risk
Current Rheumatology Reviews Fluorescence Imaging in Cancerology
Current Molecular Imaging (Discontinued) Research Toward Potassium Channels on Tumor Progression
Current Topics in Medicinal Chemistry Management of Fallopian Tube Cancer
Reviews on Recent Clinical Trials Microtubules in Apoptosis Induction: Are They Necessary?
Current Cancer Drug Targets A Review of IGF1 Signaling and IGF1-related Long Noncoding RNAs in Chemoresistance of Cancer
Current Cancer Drug Targets CD93: Recent Advances and Implications in Disease
Current Drug Targets Nanomaterials for Photohyperthermia: A Review
Current Pharmaceutical Design Image Fusion of Diagnostic Ultrasound with Other Modalities
Current Medical Imaging